Sex differences in cardiovascular risk factors and disease prevention

Atherosclerosis

Volumn 241, Issue 1, 2014, Pages 211-218

  Appelman, Yolande ^a   van Rijn, Bas B ^b,c   ten Haaf, Monique E ^a   Boersma, Eric ^d   Peters, Sanne A E ^b,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular disease; Gender; Prevention; Risk factors; Sex differences

Indexed keywords

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; HUMAN; LIFESTYLE; MALE; MORTALITY; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LIFE STYLE; MALE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84937849618     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.01.027     Document Type: Article

References (102)

1. Global Status Report on Noncommunicable Diseases 2010 2011, World Health Organization, Geneva.
2. Global Atlas on Cardiovascular Disease Prevention and Control 2011, World Health Organization, Geneva.
3. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov, 3(11):e442.
4. European Cardiovascular Disease Statistics 2012, 2012 edition, European Heart Network and European Society of Cardiology.
5. Mosca L., Grundy S.M., Judelson D., et al. Guide to preventive cardiology for women. AHA/ACC scientific statement consensus panel statement. Circulation 1999 May 11, 99(18):2480-2484.
6. Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002 Jul 20, 325(7356):157-160.
7. Veltman-Verhulst S.M., van Rijn B.B., Westerveld H.E., et al. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause 2010 Sep, 17(5):990-996.
8. Ray J.G., Vermeulen M.J., Schull M.J., et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005 Nov 19, 366(9499):1797-1803.
9. Kruit M.C., van Buchem M.A., Hofman P.A., et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 Jan 28, 291(4):427-434.
10. Mancia G., Rosei E.A., Ambrosioni E., et al. Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J. Hypertens. 2011 Feb, 29(2):309-318.
11. Mosca L., Appel L.J., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women. American heart association scientific statement. Arterioscler. Thromb. Vasc. Biol. 2004 Mar, 24(3):e29-e50.
12. Bushnell C., McCullough L.D., Awad I.A., et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the american heart association/American stroke association. Stroke 2014 May, 45(5):1545-1588.
13. Nichols M., Townsend N., Luengo-Fernandez R., et al. European Cardiovascular Disease Statistics 2012, European Heart Network, Brussels, (European Society of Cardiology, Sophia Antipolis).
14. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks 2009, World Health Organization, Geneva.
15. Kearney P.M., Whelton M., Reynolds K., et al. Worldwide prevalence of hypertension: a systematic review. J. Hypertens. 2004 Jan, 22(1):11-19.
16. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005 Jan 15, 365(9455):217-223.
17. Danaei G., Finucane M.M., Lin J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011 Feb 12, 377(9765):568-577.
18. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010 May 26, 303(20):2043-2050.
19. O'Donnell M.J., Xavier D., Liu L., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010 Jul 10, 376(9735):112-123.
20. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11, 364(9438):937-952.
21. Lewington S., Clarke R., Qizilbash N., et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 Dec 14, 360(9349):1903-1913.
22. Lawes C.M., Rodgers A., Bennett D.A., et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J. Hypertens. 2003 Apr, 21(4):707-716.
23. Peters S.A., Huxley R.R., Woodward M. Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals. Stroke 2013 Sep, 44(9):2394-2401.
24. Pereira M., Lunet N., Azevedo A., et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J. Hypertens. 2009 May, 27(5):963-975.
25. Eriksen M., MJRH The Tobacco Atlas 2012, American Cancer Society, Atlanta, GA, New York, NY: World Lung Foundation. fourth ed.
26. Hitchman S.C., Fong G.T. Gender empowerment and female-to-male smoking prevalence ratios. Bull. World Health Organ 2011 Mar 1, 89(3):195-202.
27. Giovino G.A., Mirza S.A., Samet J.M., et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012 Aug 18, 380(9842):668-679.
28. Lopez A.D., CNPT A Descriptive Model of the Cigarette Epidemic in Developed Countries 1994, 242-247. Tob Control. third ed.
29. Prescott E., Hippe M., Schnohr P., et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998 Apr 4, 316(7137):1043-1047.
30. Woodward M., Lam T.H., Barzi F., et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int. J. Epidemiol. 2005 Oct, 34(5):1036-1045.
31. Huxley R.R., Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011 Oct 8, 378(9799):1297-1305.
32. Peters S.A., Huxley R.R., Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 2013 Oct, 44(10):2821-2828.
33. Woodward M., Tunstall-Pedoe H., Smith W.C., et al. Smoking characteristics and inhalation biochemistry in the Scottish population. J. Clin. Epidemiol. 1991, 44(12):1405-1410.
34. Danaei G., Finucane M.M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011 Jul 2, 378(9785):31-40.
35. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American heart association. J. Am. Coll. Cardiol. 2011 Mar 22, 57(12):1404-1423.
36. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006 Jan 14, 332(7533):73-78.
37. Peters S.A., Huxley R.R., Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 2014 Jun 7, 383(9933):1973-1980.
38. Ferrara A., Mangione C.M., Kim C., et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: translating research into action for diabetes (TRIAD) study. Diabetes Care 2008 Jan, 31(1):69-74.
39. Kramer H.U., Raum E., Ruter G., et al. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovasc Diabetol. 2012, 11:88.
40. Wexler D.J., Grant R.W., Meigs J.B., et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005 Mar, 28(3):514-520.
41. Gouni-Berthold I., Berthold H.K., Mantzoros C.S., et al. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 2008 Jul, 31(7):1389-1391.
42. Winston G.J., Barr R.G., Carrasquillo O., et al. Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the multi-ethnic study of atherosclerosis (MESA). Diabetes Care 2009 Aug, 32(8):1467-1469.
43. Franzini L., Ardigo D., Cavalot F., et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND IT study group of the Italian society of diabetology. Nutr. Metab. Cardiovasc Dis. 2013 Mar, 23(3):235-241.
44. Penno G., Solini A., Bonora E., et al. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. J. Intern Med. 2013 Aug, 274(2):176-191.
45. National Diabetes Audit 2012-2013-Report 1: Care Processes and Treatment Targets 2014, Health and Social Care Information Centre.
46. Diabetes Atlas 2011, International Diabetes Federation, Brussels, Belgium. fifth ed.
47. Beckman J.A., Paneni F., Cosentino F., et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur. Heart J. 2013 Aug, 34(31):2444-2452.
48. Paneni F., Beckman J.A., Creager M.A., et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J. 2013 Aug, 34(31):2436-2443.
49. Evans R.W., Orchard T.J. Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction?. Metabolism 1994 Sep, 43(9):1196-1200.
50. Howard B.V., Cowan L.D., Go O., et al. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The strong heart study. Diabetes Care 1998 Aug, 21(8):1258-1265.
51. Mansfield M.W., Heywood D.M., Grant P.J. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 1996 Jan, 16(1):160-164.
52. Ossei-Gerning N., Wilson I.J., Grant P.J. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb. Haemost. 1998 Apr, 79(4):736-740.
53. Steinberg H.O., Paradisi G., Cronin J., et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000 May 2, 101(17):2040-2046.
54. Wannamethee S.G., Papacosta O., Lawlor D.A., et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British regional heart study and British women's heart health study. Diabetologia 2012 Jan, 55(1):80-87.
55. Garaulet M., Perex-Llamas F., Fuente T., et al. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur. J. Endocrinol. 2000 Nov, 143(5):657-666.
56. Donahue R.P., Rejman K., Rafalson L.B., et al. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York study. Diabetes Care 2007 Feb, 30(2):354-359.
57. Haffner S.M., Miettinen H., Stern M.P. Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 1997 Jun, 40(6):711-717.
58. Ezzati M., Lopez A.D., Rodgers A., et al. Selected major risk factors and global and regional burden of disease. Lancet 2002 Nov 2, 360(9343):1347-1360.
59. Finucane M.M., Stevens G.A., Cowan M.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011 Feb 12, 377(9765):557-567.
60. Wormser D., Kaptoge S., Di A.E., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011 Mar 26, 377(9771):1085-1095.
61. Whitlock G., Lewington S., Sherliker P., et al. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 2009 Mar 28, 373(9669):1083-1096.
62. Ni M.C., Rodgers A., Pan W.H., et al. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310,000 participants. Int. J. Epidemiol. 2004 Aug, 33(4):751-758.
63. Peters S.A., Woodward M., Lam T.H., et al. Sex disparities in risk and risk factors for ischemic heart disease in the Asia-Pacific region. Eur. J. Prev. Cardiol. 2014 May, 21(5):639-646.
64. Matthews K.A., Meilahn E., Kuller L.H., et al. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 1989 Sep 7, 321(10):641-646.
65. Farzadfar F., Finucane M.M., Danaei G., et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011 Feb 12, 377(9765):578-586.
66. Di A.E., Sarwar N., Perry P., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009 Nov 11, 302(18):1993-2000.
67. Lewington S., Whitlock G., Clarke R., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007 Dec 1, 370(9602):1829-1839.
68. Zhang X., Patel A., Horibe H., et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int. J. Epidemiol. 2003 Aug, 32(4):563-572.
69. Rich-Edwards J.W., Fraser A., Lawlor D.A., et al. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?. Epidemiol. Rev. 2014, 36(1):57-70.
70. Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 2011 Aug, 25(4):391-403.
71. Bellamy L., Casas J.P., Hingorani A.D., et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 Nov 10, 335(7627):974.
72. Smith G.N., Pudwell J., Walker M., et al. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J. Obstet. Gynaecol. Can. 2012 Sep, 34(9):830-835.
73. van Rijn B.B., Nijdam M.E., Bruinse H.W., et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet. Gynecol. 2013 May, 121(5):1040-1048.
74. Hermes W., Franx A., van Pampus M.G., et al. 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. BMC Pregnancy Childbirth 2010, 10:28.
75. Ben-Haroush A., Yogev Y., Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet. Med. 2004 Feb, 21(2):103-113.
76. Bellamy L., Casas J.P., Hingorani A.D., et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009 May 23, 373(9677):1773-1779.
77. Tam W.H., Ma R.C., Yang X., et al. Cardiometabolic risk in chinese women with prior gestational diabetes: a 15-year follow-up study. Gynecol. Obstet. Invest 2012, 73(2):168-176.
78. Pirkola J., Pouta A., Bloigu A., et al. Prepregnancy overweight and gestational diabetes as determinants of subsequent diabetes and hypertension after 20-year follow-up. J. Clin. Endocrinol. Metab. 2010 Feb, 95(2):772-778.
79. Retnakaran R., Shah B.R. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009 Sep 15, 181(6-7):371-376.
80. Lykke J.A., Langhoff-Roos J., Sibai B.M., et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009 Jun, 53(6):944-951.
81. Carr D.B., Utzschneider K.M., Hull R.L., et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006 Sep, 29(9):2078-2083.
82. Lykke J.A., Paidas M.J., Triche E.W., et al. Fetal growth and later maternal death, cardiovascular disease and diabetes. Acta Obstet. Gynecol. Scand. 2012 Apr, 91(4):503-510.
83. Lykke J.A., Langhoff-Roos J. First trimester bleeding and maternal cardiovascular morbidity. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012 Oct, 164(2):138-141.
84. Lykke J.A., Paidas M.J., Damm P., et al. Preterm delivery and risk of subsequent cardiovascular morbidity and type-II diabetes in the mother. BJOG 2010 Feb, 117(3):274-281.
85. Catov J.M., Newman A.B., Sutton-Tyrrell K., et al. Parity and cardiovascular disease risk among older women: how do pregnancy complications mediate the association?. Ann. Epidemiol. 2008 Dec, 18(12):873-879.
86. Caughey A.B., Stotland N.E., Washington A.E., et al. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet. Gynecol. 2005 Jul, 106(1):156-161.
87. Bouchard P., Fauser B.C. PCOS: an heterogeneous condition with multiple faces for multiple doctors. Eur. J. Endocrinol. 2014 Oct, 171(4):E1-E2.
88. Daan N.M., Louwers Y.V., Koster M.P., et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?. Fertil. Steril. 2014 Sep 16.
89. Moran L.J., Misso M.L., Wild R.A., et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 2010 Jul, 16(4):347-363.
90. Shaw L.J., Bairey Merz C.N., Azziz R., et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the national institutes of health-national heart, lung, and blood institute sponsored women's ischemia syndrome evaluation. J. Clin. Endocrinol. Metab. 2008 Apr, 93(4):1276-1284.
91. Atsma F., Bartelink M.L., Grobbee D.E., et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006 Mar, 13(2):265-279.
92. De Vos M., Devroey P., Fauser B.C. Primary ovarian insufficiency. Lancet 2010 Sep 11, 376(9744):911-921.
93. Roeters van Lennep J.E., Heida K.Y., Bots M.L., et al. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2014 Oct 20, Epub ahead of print.
94. Luborsky J.L., Meyer P., Sowers M.F., et al. Premature menopause in a multi-ethnic population study of the menopause transition. Hum. Reprod. 2003 Jan, 18(1):199-206.
95. Schmidt J., Landin-Wilhelmsen K., Brannstrom M., et al. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J. Clin. Endocrinol. Metab. 2011 Dec, 96(12):3794-3803.
96. Wild S., Pierpoint T., McKeigue P., et al. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf) 2000 May, 52(5):595-600.
97. Oliver-Williams C.T., Heydon E.E., Smith G.C., et al. Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis. Heart 2013 Nov, 99(22):1636-1644.
98. Kharazmi E., Dossus L., Rohrmann S., et al. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 2011 Jan, 97(1):49-54.
99. Catov J.M., Wu C.S., Olsen J., et al. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann. Epidemiol. 2010 Aug, 20(8):604-609.
100. Lykke J.A., Langhoff-Roos J., Lockwood C.J., et al. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr. Perinat. Epidemiol. 2010 Jul 1, 24(4):323-330.
101. Smith G.D., Whitley E., Gissler M., et al. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet 2000 Dec 16, 356(9247):2066-2067.
102. Irgens H.U., Reisaeter L., Irgens L.M., et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001 Nov 24, 323(7323):1213-1217.